111 related articles for article (PubMed ID: 24965897)
1. MRI for differentiation of renal cell carcinoma with sarcomatoid component from other renal tumor types.
Takeuchi M; Kawai T; Suzuki T; Naiki T; Kawai N; Fujiyoshi Y; Inagaki H; Kohri K; Hara M; Shibamoto Y
Abdom Imaging; 2015 Jan; 40(1):112-9. PubMed ID: 24965897
[TBL] [Abstract][Full Text] [Related]
2. Characteristic MRI findings of sarcomatoid renal cell carcinoma dedifferentiated from clear cell renal carcinoma: radiological-pathological correlation.
Takeuchi M; Urano M; Hara M; Fujiyoshi Y; Inagaki H; Shibamoto Y
Clin Imaging; 2013; 37(5):908-12. PubMed ID: 23834905
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging (MRI) helps differentiate renal cell carcinoma with sarcomatoid differentiation from renal cell carcinoma without sarcomatoid differentiation.
Takeuchi M; Froemming AT; Kawashima A; Thapa P; Carter RE; Cheville JC; Thompson RH; Takahashi N
Abdom Radiol (NY); 2022 Jun; 47(6):2168-2177. PubMed ID: 35381868
[TBL] [Abstract][Full Text] [Related]
5. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
[TBL] [Abstract][Full Text] [Related]
6. Comparison of T2-weighted MRI with and without fat suppression for differentiating renal angiomyolipomas without visible fat from other renal tumors.
Chung MS; Choi HJ; Kim MH; Cho KS
AJR Am J Roentgenol; 2014 Apr; 202(4):765-71. PubMed ID: 24660704
[TBL] [Abstract][Full Text] [Related]
7. Value of T2-weighted MR imaging in differentiating low-fat renal angiomyolipomas from other renal tumors.
Choi HJ; Kim JK; Ahn H; Kim CS; Kim MH; Cho KS
Acta Radiol; 2011 Apr; 52(3):349-53. PubMed ID: 21498374
[TBL] [Abstract][Full Text] [Related]
8. MRI findings of sarcomatoid renal cell carcinoma in nine cases.
Rosenkrantz AB; Chandarana H; Melamed J
Clin Imaging; 2011; 35(6):459-64. PubMed ID: 22040791
[TBL] [Abstract][Full Text] [Related]
9. Unenhanced CT and MRI Parameters That Can Be Used to Reliably Predict Fat-Invisible Angiomyolipoma.
Jeong CJ; Park BK; Park JJ; Kim CK
AJR Am J Roentgenol; 2016 Feb; 206(2):340-7. PubMed ID: 26797361
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
[TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
13. Sarcomatoid renal cell carcinoma: MRI features and their association with survival.
Cheng M; Duzgol C; Kim TH; Ghafoor S; Becker AS; Causa Andrieu PI; Gangai N; Jiang H; Hakimi AA; Vargas HA; Woo S
Cancer Imaging; 2023 Feb; 23(1):16. PubMed ID: 36793052
[TBL] [Abstract][Full Text] [Related]
14. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
15. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
Choi YA; Kim CK; Park SY; Cho SW; Park BK
AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
[TBL] [Abstract][Full Text] [Related]
16. Significance of the pseudocapsule on MRI of renal neoplasms and its potential application for local staging: a retrospective study.
Roy C; El Ghali S; Buy X; Lindner V; Lang H; Saussine C; Jacqmin D
AJR Am J Roentgenol; 2005 Jan; 184(1):113-20. PubMed ID: 15615960
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
[TBL] [Abstract][Full Text] [Related]
18. Staging and differential diagnosis of renal cell carcinoma: a comparison of magnetic resonance imaging (MRI) and computed tomography (CT).
Nishimura K; Hida S; Okada K; Yoshida O; Nishimuara K
Hinyokika Kiyo; 1988 Aug; 34(8):1323-31. PubMed ID: 3195400
[TBL] [Abstract][Full Text] [Related]
19. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
[TBL] [Abstract][Full Text] [Related]
20. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
